Trial Testing Lonca-R in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
This phase 3 trial is designed to compare loncastuximab tesirine plus rituximab with standard immunochemotherapy in patients with relapsed or refractory diffuse large B-cell lymphoma.